All prison inmates will be eligible to receive COVID-19 vaccine by mid-May, officials say
All inmates will be provided the opportunity to receive a COVID-19 vaccination by mid-May, the Federal Bureau of Prisons announced Thursday.
Biden administration to invest $1.7B to identify, track coronavirus variants
The Biden administration says the U.S. is setting up a $1.7 billion national network to identify and track worrisome coronavirus mutations whose spread could trigger another pandemic wave.
APH pauses use of Johnson & Johnson COVID-19 vaccine
APH has notified local health care providers that it is following the federal recommendation to pause use of the Johnson & Johnson COVID-19 vaccine.
Pfizer CEO says third dose of vaccine 'likely' needed within 1 year
The CEO of pharmaceutical giant Pfizer said during a televised interview Thursday that people will "likely" need a third dose of the COVID-19 vaccine.
CDC identifies 5,800 COVID-19 ‘breakthrough infections’ among 75 million fully vaccinated people
The U.S. Centers for Disease Control and Prevention says it has identified a comparatively small group of fully vaccinated people who have reported “breakthrough” COVID-19 infections, which should be “expected.”
Lack of vaccines in other parts of world puts US at risk, could prolong pandemic, experts say
Dr. Anthony Fauci, the nation’s leading expert on infectious diseases, said the longer the novel coronavirus is allowed to replicate in any part of the world, the more opportunity new variants have to emerge and threaten the country’s chance of reaching herd immunity.
What you need to know about your COVID-19 vaccine card, and what to do if you lose it
Here are some answers to common questions about COVID-19 vaccine cards, including what happens if it is lost or damaged.
US opens more distance in worldwide race against COVID-19 as it nears 200M vaccines administered
Nearly half of American adults have gotten at least one dose of the vaccine, and about 30% have been fully vaccinated. But the picture is still relentlessly grim in parts of Europe, Latin America, Africa and Asia.
Williamson County to stop accepting names on COVID-19 vaccine waitlist
Williamson County says it will no longer be accepting names on its COVID-19 vaccine waitlist starting Friday, April 16 at 5 p.m.
Kelley Reeves Athletic Complex stopping vaccinations early due to weather
Officials say that all Thursday appointments are being moved to Monday, April 19.
Potential HIV vaccine utilizing same mRNA technology as COVID-19 vaccine shows promise in early human trial
A potential HIV vaccine that utilizes he same mRNA technology as the COVID-19 vaccine from Moderna is showing promising results.
J&J COVID-19 vaccine pause to remain in place while officials seek more evidence on rare clots
The pause on Johnson & Johnson’s COVID-19 vaccine will remain in place for now after U.S. health advisers said they need more evidence to make any decision about the rare blood clots reported.
Moderna CEO says company anticipates ‘a lot of variants’ of coronavirus in next year
Moderna CEO Stéphane Bancel said he anticipates the world will see many coronavirus variants over “the next year or so” and hopes to have a booster shot by the fall.
NFL says more than 2M COVID-19 vaccines administered at its stadiums
The NFL announced Wednesday that more than 2 million COVID-19 vaccinations have been administered at its stadiums and facilities since starting the campaign earlier this year.
Texas DSHS recommends pause on J&J vaccine administration
The news about the Johnson & Johnson COVID-19 vaccine may be alarming, but some health officials say people shouldn't worry.
NFL to restrict access of team employees who refuse COVID-19 vaccine without ‘bona fide’ reason
The NFL is requiring certain team employees to have a “bona fide” reason to forego the COVID-19 vaccine or get barred from restricted areas.
CDC investigating death possibly connected to Johnson & Johnson vaccine
The death of a woman who received the single-dose Johnson & Johnson vaccine is under investigation by federal health authorities as part of a broader probe into potential "adverse side effects" from the vaccine.
Johnson & Johnson pauses COVID-19 vaccine trial after US recommends investigation of rare clotting reports
Johnson & Johnson said it will pause an ongoing trial of its COVID-19 vaccine after federal health officials recommended the action in the wake of six reported U.S. cases of a rare type of blood clotting following vaccination.
Moderna says its COVID-19 vaccine greater than 90% effective against virus 6 months after second shot
Moderna said its latest Phase 3 clinical trial found that its vaccine remains greater than 90% effective against COVID-19, and greater than 95% effective against severe cases of COVID-19, six months after the second dose.
Georgia site stops Johnson & Johnson vaccinations after adverse reactions
A Georgia COVID-19 vaccination site is pausing using the Johnson & Johnson vaccine after multiple people experienced adverse reactions.